The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapValue
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PJP | 84.59 | 0.76 | +0.91% |
| Invesco Pharmaceuticals ETF | |||
| UST | 42.18 | 0.05 | +0.12% |
| ProShares Ultra 7-10 Year Treasury | |||
| EMXF | 38.25 | -0.19 | -0.49% |
| iShares ESG Advanced MSCI EM ETF | |||
| FYX | 105.80 | -0.94 | -0.88% |
| First Trust Small Cap Core AlphaDEX® ETF | |||
| EMXC | 57.03 | -0.58 | -1.01% |
| iShares MSCI Emerging Mkts ex China ETF | |||
A.I.dvisor indicates that over the last year, TRMCX has been closely correlated with VEVYX. These tickers have moved in lockstep 95% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRMCX jumps, then VEVYX could also see price increases.
| Ticker / NAME | Correlation To TRMCX | 1D Price Change % | ||
|---|---|---|---|---|
| TRMCX | 100% | -0.67% | ||
| VEVYX - TRMCX | 95% Closely correlated | N/A | ||
| MVCAX - TRMCX | 86% Closely correlated | -1.04% | ||
| JVMAX - TRMCX | 85% Closely correlated | -1.18% | ||
| JVMRX - TRMCX | 76% Closely correlated | -1.18% | ||
| JVMSX - TRMCX | 75% Closely correlated | -1.16% | ||
More | ||||